Anebulo Pharmaceuticals, Inc. (ANEB) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $11.66M | +205.8% |
| 2024 | $3.81M | -64.0% |
| 2023 | $10.60M | -29.6% |
| 2022 | $15.07M | -29.6% |
| 2021 | $21.41M | +12611.5% |
| 2020 | -$171.1K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $11.66M | +205.8% |
| 2024 | $3.81M | -64.0% |
| 2023 | $10.60M | -29.6% |
| 2022 | $15.07M | -29.6% |
| 2021 | $21.41M | +12611.5% |
| 2020 | -$171.1K | — |